Hallucinogenic drug induced states resemble acute endogenous psychoses: Results of an empirical study

European Psychiatry

Volumn 13, Issue 8, 1998, Pages 399-406

  Gouzoulis Mayfrank, E ^a   Habermeyer, E ^a   Hermle, L ^b   Steinmeyer, A M ^a   Kunert, H J ^a   Sass, H ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Christophsbad   (Germany)

Author keywords

Altered states of consciousness (ASC); Hallucinogens; Psychedelics; Psychopathology; Schizophrenia

Indexed keywords

PSYCHEDELIC AGENT;

ACUTE DISEASE; ADULT; ARTICLE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPATHY; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SELF EVALUATION;

EID: 0032230203     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(99)80686-5     Document Type: Article

References (38)

1. Die exogenen reaktionstypen
2. 'Psychedelic' experiences in acute psychosis
3. The early symptoms of schizophrenia
4. Die symptomatischen psychosen
5. International study on altered states of consciousness (ISASC). Summary of the results
6. Dreams, hallucinogenic drug states, and schizophrenia: A psychological and biological comparison
7. Early subjective experience in schizophrenic episodes
8. Psychedelic experiences at the beginning of acute endogenous psychotic episodes
9. Ausdrucksphanomenologie der modellpsychosen (Psilocybin)
10. The Brief Psychiatric Rating Scale (BPRS): A comprehensive review
11. Mescaline-induced psychopathological, neuropsychological and neurometabolic effects in normal subjects. Experimental psychosis as a tool for psychiatric research
12. The significance of hallucinogenic research in psychiatry: History and present status
13. Drug-induced psychoses and schizophrenic reactions, a critical comparison
14. Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans
15. Erwartete fitwerte fur zufallskonfigurationen in PINDIS
16. Procrustean individual difference scaling
17. Altered states of consciousness
18. Symptom differences in schizophrenia with good and poor prognosis
19. Brief psychiatric rating scale
20. Hallucinogens
21. Experimental schizophrenia-like symptoms
22. Experimental psychiatry II: Clinical and physiochemical observations in experimental psychosis
23. Increased activation of indirect semantic associations under Psilocybin
24. A clinical study of the mescaline psychosis, with special reference to the mechanism of the genesis of schizophrenic and other psychotic states
25. Hallucinogenic drugs in psychiatric research ad treatment. Perspectives and prospects
26. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects
27. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans
28. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale
29. Disturbance of serotonergic or glutamatergic neurotransmission results in hyperfrontality as measured by PET and FDG in acute human model psychoses
30. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
31. The frequency of visual hallucinations in schizophrenic patients in Saudi Arabia